Company Active LTD

Company profile

Ibex Innovations Ltd

Home - IBEX Innovations

Supporting healthy ageing through early diagnosis The Bone Health Company IBEX is on a mission to support healthy ageing for all by providing routine access to osteoporosis diagnosis Learn More Osteoporosis diagnosis from routine X-ray IBEX BH automatically reports fracture risk from routine radiology, requiring no change to system hardware of imaging protocols Learn More

CRN
07208355
Founded
2010
Age
16

Overview

Legal name
IBEX INNOVATIONS LTD
Region
North East England
Registered address
NETPARK PLEXUS THOMAS WRIGHT WAY
SEDGEFIELD
STOCKTON-ON-TEES
ENGLAND
TS21 3FD
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

3 levels 5 ultimate controllers
1
Company Active LTD
Ibex Innovations Ltd
CRN 07208355
2
Direct controller Active LTD
3
Direct controller Active LTD
4
Direct controller Active LTD
5
Direct controller Active LTD
6
Direct controller Active LTD
7
Intermediate controller Active LTD
8
Intermediate controller Active LTD
9
Intermediate controller Active LTD
10
Intermediate controller Active LLP
Primount LLP
CRN OC388523
11
Ultimate controller Active PLC
Ip Group PLC
CRN 04204490
12
Ultimate controller Active PRIVATE-LIMITED-GUARANT-NSC
13
Ultimate controller Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION
14
Ultimate controller Active LTD
15
Ultimate controller
OHIO 164495
CRN OHIO 164495

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
-£1,256,991
Employees
20

Company events

Reference milestones and recent Companies House filing stream events.

8 events
13 Apr
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

12 Apr
2026

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzUxNTM2NjQ5MGFkaXF6a2N4

Published 12 Apr 2026 05:40

30 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

20 Feb
2025

Capital Allotment Shares

Capital

SH01 | Transaction MzQ1NTgwMDk1MGFkaXF6a2N4

Published 20 Feb 2025 09:50

11 Oct
2024

Accounts With Accounts Type Small

Accounts Analysed

AA | Transaction MzQzOTE0MzcxMWFkaXF6a2N4

Published 11 Oct 2024 08:34

30 Mar
2010

Incorporated

Inception

Company registered at Companies House

Public funding

19 awards
First funded
2012
Funded years
2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2022, 2023, 2024, 2025
Age at first award
2 years

Projects

2025 Collaborative R&D Lead participant

Fracture Risk and Osteoporosis Diagnosis on X-rays

1 May 2025 to 30 Apr 2027

Awarded
£261,736
Total cost £436,226

no public description

2024 Collaborative R&D Lead participant

IBEX BH on Mammography Clinical Feasibility Study

1 May 2024 to 30 Apr 2025

Awarded
£95,230
Total cost £95,230

Osteoporosis is a serious health problem for older women. Fracture rates for weak bones exceed rates for heart attacks, stroke and breast cancer combined\[12\]. Complications resulting from hip fractures can be fatal, with a quarter of women aged 50 or over dying within a year\[4\]. Long-term care following a fracture costs the NHS and Social Services mor...

2023 Collaborative R&D Lead participant

IBEX bone health screening on mammography systems

1 Nov 2023 to 31 Oct 2024

Awarded
£141,856
Total cost £202,651

This project will demonstrate a unique method of screening for osteoporosis using widely available mammography services and screening programs. Osteoporosis is a condition that affects over 20% of women over the age of 50\. Fragility fractures resulting from the condition have a devastating impact on health, mortality and quality of life and cost the glob...

2022 Collaborative R&D Lead participant

Reducing osteoporosis treatment backlog with IBEX Trueview fracture risk prediction software tool on standard plain radiographs

1 Nov 2022 to 30 Apr 2024

Awarded
£145,457
Total cost £207,795

Trueview is an advanced software product that enables bone health diagnoses to be made using standard X-ray scans, rather than the specialised DXA scans currently required. The technology has been shown to provide accurate diagnosis of osteoporosis on forearm X-rays and this project will further develop the technology to allow it to be used on a wider ran...

2022 Collaborative R&D Lead participant

Feasibility of Opportunistic Bone Health Screening Using Chest X-rays

1 Sep 2022 to 28 Feb 2023

Awarded
£90,463
Total cost £129,233

Osteoporosis is a debilitating disease that leads to deterioration of bone structure and density, resulting in a significantly increased risk of fragility fractures. An estimated 17% of men and 34% of women are affected by osteoporosis worldwide and in 2017, fragility fractures cost the UK €5.5bn with an associated one-year mortality rate of 33%. This pro...

2020 Collaborative R&D Lead participant

Improved efficiencies during health emergencies through enhanced visualisation of tubes and lines in the ITU setting

1 Nov 2020 to 30 Apr 2021

Awarded
£80,893
Total cost £80,893

The Covid-19 pandemic has seen a huge increase in the number of hospital admissions for patients requiring care in intensive therapy/care units (ITU). These patients are often critically ill, immobile and in need of rapid interventions to assist with breathing, feeding and deployment of other health support systems. This influx has also highlighted how in...

2020 Feasibility Studies Lead participant

Continuity grant to facilitate ongoing R&D into AI Assisted Diagnosis using IBEX Trueview.

1 Jun 2020 to 30 Nov 2020

Awarded
£100,000
Total cost £100,000

no public description

2020 Study Lead participant

Innovative multi-channel AI method for the improved diagnosis of upper extremity bone fractures in the trauma setting.

1 Apr 2020 to 30 Jun 2021

Awarded
£288,136
Total cost £411,623

This project will develop the proof of concept of an innovative multi-channel AI method to improve the prevention and diagnosis of fragility fractures. Digital radiology (DR) remains the standard imaging protocol for fracture detection after trauma and whilst the majority of pathologies are correctly identified, a significant proportion are missed, leadin...

2019 Collaborative R&D Lead participant

IBEX Enhanced X-ray Mammography

1 May 2019 to 31 Jul 2021

Awarded
£700,845
Total cost £1,401,689

"The project will develop and commercialise novel technologies to radically improve the safety, effectiveness and patient comfort of X-ray breast imaging. Firstly, the project will adapt the IBEX Trueview(r) gridless scatter correction method for use in mammography and Digital Breast Tomosynthesis (DBT) systems and demonstrate its effectiveness to reduce ...

2018 Feasibility Studies Lead participant

Enhanced food contaminant detection system incorporating a novel multi-spectral X-ray imaging technology

1 Jan 2018 to 31 Jan 2019

Awarded
£109,136
Total cost £155,910

"The project aims to demonstrate a production-compatible X-ray food inspection system capable of reliably detecting both plastic contaminants during the manufacture of chocolate confectionary products, and bone fragments in the meat processing industry. The project will combine a novel multi-spectral X-ray imaging technology from IBEX Innovations Limited ...

2017 Feasibility Studies Lead participant

IBEX Enhanced Cone Beam Computed Tomography (eCBCT)

1 Aug 2017 to 31 Jul 2018

Awarded
£132,713
Total cost £189,590

IBEX Innovations has recognised an opportunity to adapt its patented X-ray detector technology to Cone Beam Computed Tomography (CBCT). CBCT is a medical X-ray imaging technique that enables 3D reconstructions of body parts to be collected using a much simpler, cheaper and more flexible set-up compared to conventional Computed Tomography (CT) systems. How...

2017 Feasibility Studies Lead participant

Enhanced mammography X-ray detector

1 May 2017 to 31 Jan 2018

Awarded
£69,901
Total cost £99,859

Mammography is a widely-adopted X-ray screening method used to detect and diagnose breast cancer earlier. Abnormalities in the breast are identified through contrast changes in the X-ray image. X-ray mammography is the only mass screening programme where patients are exposed to ionising radiation in a radio-sensitive organ, increasing the risk of radiatio...

Product types

Collaborative R&D Feasibility Studies GRD Development of Prototype GRD Proof of Concept GRD Proof of Market Study Vouchers